Julie-Anne Tanner1,2, Jeffrey A Henderson3, Dedra Buchwald4, Barbara V Howard5, Patricia Nez Henderson3, Rachel F Tyndale1,2,6. 1. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada. 2. Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. 3. Black Hills Center for American Indian Health, Rapid City, South Dakota. 4. Elson S. Floyd College of Medicine, Initiative for Research and Education to Advance Community Health (IREACH), Washington State University, Seattle, WA. 5. MedStar Health Research Institute, Hyattsville, MD; the Georgetown-Howard Universities Center for Clinical and Translational Sciences, Washington, DC. 6. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Abstract
Introduction: Smoking prevalence, cigarettes per day (CPD), and lung cancer incidence differ between Northern Plains (NP) and Southwest (SW) American Indian populations. We used cotinine as a biomarker of tobacco smoke exposure to biochemically characterize NP and SW smokers and nonsmokers and to investigate factors associated with variation in tobacco exposure. Methods: American Indians (N = 636) were recruited from two different tribal populations (NP and SW) as part of a study conducted as part of the Collaborative to Improve Native Cancer Outcomes P50 project. For each participant, a questionnaire assessed smoking status, CPD, second-hand smoke exposure, and traditional ceremonial tobacco use; plasma and/or salivary cotinine was measured. Results: Cotinine levels were (mean ± 95% confidence interval [CI]) 81.6 ± 14.1 and 21.3 ± 7.3 ng/ml among NP smokers and non-mokers, respectively, and 44.8 ± 14.4 and 9.8 ± 5.8 ng/ml among SW smokers and nonsmokers, respectively. Cotinine levels correlated with CPD in both populations (p < .0001). Cotinine ≥15 ng/ml was measured in 73.4% of NP smokers and 47.8% of SW smokers and in 19.0% of NP nonsmokers and 10.9% of SW nonsmokers. Ceremonial traditional tobacco use was associated with higher cotinine among NP smokers only (p = 0.004). Second-hand smoke exposure was associated with higher cotinine among NP non-smokers (P < 0.02). More secondhand smoke exposure was associated with smoking more CPD in both populations (p = 0.03-0.29). Linear regression modeling mirrored these findings. Conclusions: High prevalence of smoking in the Northern Plains and high cotinine levels among nonsmokers in both regions highlights the tribal populations' risk for tobacco-related disease. Implications: There is a high prevalence of smoking in Northern Plains American Indians. Among Northern Plains and Southwest nonsmokers, relatively high cotinine levels, representative of high tobacco exposure, suggest considerable exposure to second-hand smoke. It is critical to highlight the extent of second-hand smoke exposure among the Northern Plains and Southwest American Indians and to enhance efforts to initiate smoke-free policies in tribal communities, which are not subject to state-level polices.
Introduction: Smoking prevalence, cigarettes per day (CPD), and lung cancer incidence differ between Northern Plains (NP) and Southwest (SW) American Indian populations. We used cotinine as a biomarker of tobacco smoke exposure to biochemically characterize NP and SW smokers and nonsmokers and to investigate factors associated with variation in tobacco exposure. Methods: American Indians (N = 636) were recruited from two different tribal populations (NP and SW) as part of a study conducted as part of the Collaborative to Improve Native Cancer Outcomes P50 project. For each participant, a questionnaire assessed smoking status, CPD, second-hand smoke exposure, and traditional ceremonial tobacco use; plasma and/or salivary cotinine was measured. Results:Cotinine levels were (mean ± 95% confidence interval [CI]) 81.6 ± 14.1 and 21.3 ± 7.3 ng/ml among NP smokers and non-mokers, respectively, and 44.8 ± 14.4 and 9.8 ± 5.8 ng/ml among SW smokers and nonsmokers, respectively. Cotinine levels correlated with CPD in both populations (p < .0001). Cotinine ≥15 ng/ml was measured in 73.4% of NP smokers and 47.8% of SW smokers and in 19.0% of NP nonsmokers and 10.9% of SW nonsmokers. Ceremonial traditional tobacco use was associated with higher cotinine among NP smokers only (p = 0.004). Second-hand smoke exposure was associated with higher cotinine among NP non-smokers (P < 0.02). More secondhand smoke exposure was associated with smoking more CPD in both populations (p = 0.03-0.29). Linear regression modeling mirrored these findings. Conclusions: High prevalence of smoking in the Northern Plains and high cotinine levels among nonsmokers in both regions highlights the tribal populations' risk for tobacco-related disease. Implications: There is a high prevalence of smoking in Northern Plains American Indians. Among Northern Plains and Southwest nonsmokers, relatively high cotinine levels, representative of high tobacco exposure, suggest considerable exposure to second-hand smoke. It is critical to highlight the extent of second-hand smoke exposure among the Northern Plains and Southwest American Indians and to enhance efforts to initiate smoke-free policies in tribal communities, which are not subject to state-level polices.
Authors: Joni A Jensen; Barbara A Schillo; Molly M Moilanen; Bruce R Lindgren; Sharon Murphy; Steven Carmella; Stephen S Hecht; Dorothy K Hatsukami Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-30 Impact factor: 4.254
Authors: Babalola Faseru; Nicole L Nollen; Matthew S Mayo; Ron Krebill; Won S Choi; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia; Lisa Sanderson Cox Journal: Addict Behav Date: 2012-11-29 Impact factor: 3.913
Authors: June E Eichner; Wenyu Wang; Ying Zhang; Elisa T Lee; Thomas K Welty Journal: Int J Environ Res Public Health Date: 2010-10-25 Impact factor: 3.390
Authors: M L Slattery; M C Schumacher; A P Lanier; S Edwards; R Edwards; M A Murtaugh; J Sandidge; G E Day; D Kaufman; S Kanekar; L Tom-Orme; J A Henderson Journal: Am J Epidemiol Date: 2007-06-22 Impact factor: 4.897
Authors: Michelle C Kegler; Katherine Anderson; Lucja T Bundy; Deana Knauf; June Halfacre; Cam Escoffery; Andre Cramblit; Patricia Henderson Journal: J Community Health Date: 2019-08
Authors: Christi A Patten; Vanessa Y Hiratsuka; Sarah H Nash; Gretchen Day; Diana G Redwood; Julie A Beans; Barbara V Howard; Jason G Umans; Kathryn R Koller Journal: Nicotine Tob Res Date: 2022-04-28 Impact factor: 5.825
Authors: Jeffrey A Henderson; Dedra S Buchwald; Barbara V Howard; Patricia Nez Henderson; Yafang Li; Rachel F Tyndale; Christopher I Amos; Olga Y Gorlova Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-08-27 Impact factor: 4.254
Authors: Krista R Schaefer; Jaedon P Avey; Michael R Todd; Julie A Beans; Denise A Dillard; Laura M Shireman; Timothy A Thornton; Rachel F Tyndale; Kenneth E Thummel; Renee F Robinson; Katrina G Claw Journal: Clin Transl Sci Date: 2021-09-14 Impact factor: 4.689